Autolus Therapeutics PLC (ADR)

General ticker "AUTL" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $755.3M

Autolus Therapeutics PLC (ADR) does not follow the US Stock Market performance with the rate: -29.9%.

Estimated limits based on current volatility of 3.5%: low 2.19$, high 2.35$

Factors to consider:

  • Current price 37.6% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.49$, 7.73$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.15$, 7.04$]

Financial Metrics affecting the AUTL estimates:

  • Negative: Non-GAAP EPS, $ of -1.19 <= 0.10
  • Negative: Operating profit margin, % of -99.14 <= 1.03
  • Negative: Operating cash flow per share per price, % of -14.99 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Positive: Interest expense per share, $ of 0.26 <= 0.74

Similar symbols

Short-term AUTL quotes

Long-term AUTL plot with estimates

Financial data

YTD 2022-12-31 2023-12-31
Operating Revenue $6.19MM $1.70MM
Operating Expenses $169.98MM $196.73MM
Operating Income $-163.78MM $-195.03MM
Non-Operating Income $-9.42MM $-13.37MM
Interest Expense $8.90MM $45.07MM
R&D Expense $141.99MM $149.98MM
Income(Loss) $-173.21MM $-208.40MM
Taxes $-24.37MM $-0.02MM
Profit(Loss) $-148.84MM $-208.38MM
Stockholders Equity $298.67MM $111.47MM
Inventory $14.16MM $0.00MM
Assets $490.27MM $375.38MM
Operating Cash Flow $-112.31MM $-145.59MM
Capital expenditure $10.84MM $10.99MM
Investing Cash Flow $-10.84MM $-10.99MM
Financing Cash Flow $223.61MM $-0.88MM
Earnings Per Share* $-1.57 $-1.20

* EPS are Split Adjusted, recent splits may be reflected with a delay.